Towards a cancer immunome database

Same author

trEST, trGEN and Hits: access to databases of predicted protein sequences.

Nucleic acids research·2000

Same author

Antigens recognized by autologous antibody in patients with renal-cell carcinoma.

International journal of cancer·1999

Same author

Differences in the recognition by CTL of peptides presented by the HLA-B4402 and the HLA-B4403 molecules which differ by a single amino acid.

Tissue antigens·1999

Same author

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

Journal of immunology (Baltimore, Md. : 1950)·1998

Same author

Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.

Proceedings of the National Academy of Sciences of the United States of America·1992

Same author

The E alpha promoter: a linker-scanning analysis.

Journal of immunology (Baltimore, Md. : 1950)·1991

Same journal

Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.

Cancer immunity·2013

Same journal

Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas.

Cancer immunity·2013

Same journal

Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.

Cancer immunity·2013

Same journal

An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.

Cancer immunity·2013

Same journal

Database of T cell-defined human tumor antigens: the 2013 update.

Cancer immunity·2013

Same journal

Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.

Cancer immunity·2013

Related Experiment Videos

Towards a cancer immunome database

Related Concept Videos

trEST, trGEN and Hits: access to databases of predicted protein sequences.

Antigens recognized by autologous antibody in patients with renal-cell carcinoma.

Differences in the recognition by CTL of peptides presented by the HLA-B4402 and the HLA-B4403 molecules which differ by a single amino acid.

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.

The E alpha promoter: a linker-scanning analysis.

Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.

Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas.

Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.

An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.

Database of T cell-defined human tumor antigens: the 2013 update.

Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.

Related Experiment Videos

Towards a cancer immunome database

Related Concept Videos

Related Articles

trEST, trGEN and Hits: access to databases of predicted protein sequences.

Antigens recognized by autologous antibody in patients with renal-cell carcinoma.

Differences in the recognition by CTL of peptides presented by the HLA-B*4402 and the HLA-B*4403 molecules which differ by a single amino acid.

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect.

The E alpha promoter: a linker-scanning analysis.

Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model.

Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas.

Expression of CD1c enhances human invariant NKT cell activation by α-GalCer.

An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.

Database of T cell-defined human tumor antigens: the 2013 update.

Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells.

Differences in the recognition by CTL of peptides presented by the HLA-B4402 and the HLA-B4403 molecules which differ by a single amino acid.